Tipsheet
What matters at India’s listed companies
Earnings · Plastic Products · Small cap

Mold-Tek crosses ₹300 cr sales, EBITDA per kg hits record ₹46.68

Q1 revenue tops ₹300 crore for the first time. Record operating margin per kilogram, led by pharma pack volumes up 38.75%.

3 earlier stories on Mold-Tek Packaging Ltd.
Mkt cap₹2,286 cr
P/E31.37×
ROE9.49%
Debt / eq.0.28
₹46.68 / kg Record EBITDA per kilogram

What's new

  • Net sales up 26.32% sequentially to ₹300.45 crore; net profit up 23.89% to ₹25.57 crore.
  • EBITDA per kg hit an all-time high of ₹46.68 on better capacity utilisation and Hyderabad consolidation.
  • Pharma packaging volume surged 38.75%; food & FMCG grew 26.20%.

Why this matters

Crossing ₹300 crore in quarterly revenue is a milestone, but the record EBITDA per kg is the real signal: better capacity utilisation and cost efficiencies are driving profitability. Pharma's 38.75% volume growth shows diversification beyond core FMCG is gaining traction.

What we're watching

  • Whether the EBITDA per kg can sustain above ₹45 as utilisation normalises.
  • Pharma segment's contribution to overall revenue in coming quarters.
  • Capacity expansion plans and any fresh capex guidance.

The full read

Mold-Tek Packaging's Q1 FY27 results are a clean beat: ₹300.45 crore in revenue (first time above that mark) and a record ₹46.68 per kg in EBITDA. The sequential growth of 26.32% in sales and 23.89% in net profit is impressive, but the per-kilogram metric matters more. It says the company is getting more out of its existing capacity, helped by the Hyderabad consolidation. Pharma packaging volumes jumped 38.75%, a signal that diversification is working. The board approved the numbers on July 27. A strong quarter, though as a regular results filing, the news was widely anticipated.

Questions answered

What drove the record EBITDA per kg of ₹46.68?
Better capacity utilisation and cost efficiencies from consolidating the Hyderabad units pushed EBITDA per kg to a historic high of ₹46.68 in Q1 FY27.
How much did the pharma packaging segment grow?
Pharma packaging volumes rose 38.75% year-on-year, supported by new customer additions. The segment is now a meaningful growth driver alongside core food and FMCG business.
Did the company provide any forward guidance?
No. The filing is a routine quarterly results announcement with no explicit revenue or margin guidance beyond normal commentary on demand and capacity.
What is the company's current market cap and valuation?
Mold-Tek Packaging has a market cap of about ₹2,286 crore, with a trailing P/E of 31.4 times and return on equity of 9.5%.
Mentioned: Mold-Tek Packaging · ₹300.45 cr revenue · ₹46.68/kg EBITDA
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Mold-Tek Packaging Ltd.

Chemicals
₹2,299 cr
P/E 30.23×

Latest quarter · Mar 2022

Sales₹178 cr
Net profit₹17 cr
Op. margin+17.9%
EPS₹5.54

Strength & growth

Debt / equity0.10×
Current ratio3.13×
Sales CAGR+12.1%
EPS CAGR−6.6%
  1. 27 Jul 2026 · 2:06 PM IST Mold-Tek crosses ₹300 cr sales, EBITDA per kg hits record ₹46.68
  2. 1d ago Mold-Tek posts record ₹46.7/kg EBITDA; lube volumes drop 17%
  3. 1d ago Mold-Tek Q1 sales top ₹300 cr, pharma packs leap 39%
  4. 1d ago Mold-Tek logs record ₹46.68/kg EBITDA in Q1, pharma packs lead growth